List of Tables
Table 1. Global Female Contraception Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Female Contraception Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Female Contraception Market Competitive Situation by Manufacturers in 2025
Table 4. Global Female Contraception Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Female Contraception Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Female Contraception Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Female Contraception Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Female Contraception Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Female Contraception, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Female Contraception, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Female Contraception, Product Types and Applications
Table 12. Global Key Manufacturers of Female Contraception, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Female Contraception Companies by Tier (Tier 1, Tier 2, Tier 3), based on Female Contraception Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Female Contraception Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Female Contraception Sales by Region (K Units), 2021–2026
Table 18. Global Female Contraception Sales Market Share by Region (2021–2026)
Table 19. Global Female Contraception Sales by Region (K Units), 2027–2032
Table 20. Global Female Contraception Sales Market Share by Region (2027–2032)
Table 21. Global Female Contraception Revenue by Region (US$ Million), 2021–2026
Table 22. Global Female Contraception Revenue Market Share by Region (2021–2026)
Table 23. Global Female Contraception Revenue by Region (US$ Million), 2027–2032
Table 24. Global Female Contraception Revenue Market Share by Region (2027–2032)
Table 25. North America Female Contraception Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Female Contraception Sales by Country (K Units), 2021–2026
Table 27. North America Female Contraception Sales by Country (K Units), 2027–2032
Table 28. North America Female Contraception Revenue by Country (US$ Million), 2021–2026
Table 29. North America Female Contraception Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Female Contraception Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Female Contraception Sales by Country (K Units), 2021–2026
Table 32. Europe Female Contraception Sales by Country (K Units), 2027–2032
Table 33. Europe Female Contraception Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Female Contraception Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Female Contraception Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Female Contraception Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Female Contraception Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Female Contraception Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Female Contraception Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Female Contraception Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Female Contraception Sales by Country (K Units), 2021–2026
Table 42. Latin America Female Contraception Sales by Country (K Units), 2027–2032
Table 43. Latin America Female Contraception Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Female Contraception Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Female Contraception Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Female Contraception Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Female Contraception Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Female Contraception Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Female Contraception Revenue by Country (US$ Million), 2027–2032
Table 50. Global Female Contraception Sales (K Units) by Type (2021–2026)
Table 51. Global Female Contraception Sales (K Units) by Type (2027–2032)
Table 52. Global Female Contraception Sales Market Share by Type (2021–2026)
Table 53. Global Female Contraception Sales Market Share by Type (2027–2032)
Table 54. Global Female Contraception Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Female Contraception Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Female Contraception Revenue Market Share by Type (2021–2026)
Table 57. Global Female Contraception Revenue Market Share by Type (2027–2032)
Table 58. Global Female Contraception Price (US$/Unit) by Type (2021–2026)
Table 59. Global Female Contraception Price (US$/Unit) by Type (2027–2032)
Table 60. Global Female Contraception Sales (K Units) by Application (2021–2026)
Table 61. Global Female Contraception Sales (K Units) by Application (2027–2032)
Table 62. Global Female Contraception Sales Market Share by Application (2021–2026)
Table 63. Global Female Contraception Sales Market Share by Application (2027–2032)
Table 64. Global Female Contraception Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Female Contraception Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Female Contraception Revenue Market Share by Application (2021–2026)
Table 67. Global Female Contraception Revenue Market Share by Application (2027–2032)
Table 68. Global Female Contraception Price (US$/Unit) by Application (2021–2026)
Table 69. Global Female Contraception Price (US$/Unit) by Application (2027–2032)
Table 70. Amgen Inc. Company Information
Table 71. Amgen Inc. Description and Business Overview
Table 72. Amgen Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Amgen Inc. Female Contraception Product
Table 74. Amgen Inc. Recent Developments/Updates
Table 75. Ansell Ltd. Company Information
Table 76. Ansell Ltd. Description and Business Overview
Table 77. Ansell Ltd. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Ansell Ltd. Female Contraception Product
Table 79. Ansell Ltd. Recent Developments/Updates
Table 80. Exeltis USA Inc. Company Information
Table 81. Exeltis USA Inc. Description and Business Overview
Table 82. Exeltis USA Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Exeltis USA Inc. Female Contraception Product
Table 84. Exeltis USA Inc. Recent Developments/Updates
Table 85. Medisafe Distribution Inc. Company Information
Table 86. Medisafe Distribution Inc. Description and Business Overview
Table 87. Medisafe Distribution Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Medisafe Distribution Inc. Female Contraception Product
Table 89. Medisafe Distribution Inc. Recent Developments/Updates
Table 90. Merck & Co. Inc. Company Information
Table 91. Merck & Co. Inc. Description and Business Overview
Table 92. Merck & Co. Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Merck & Co. Inc. Female Contraception Product
Table 94. Merck & Co. Inc. Recent Developments/Updates
Table 95. Mylan NV Company Information
Table 96. Mylan NV Description and Business Overview
Table 97. Mylan NV Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Mylan NV Female Contraception Product
Table 99. Mylan NV Recent Developments/Updates
Table 100. Pfizer Inc. Company Information
Table 101. Pfizer Inc. Description and Business Overview
Table 102. Pfizer Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Inc. Female Contraception Product
Table 104. Pfizer Inc. Recent Developments/Updates
Table 105. Piramal Enterprises Ltd. Company Information
Table 106. Piramal Enterprises Ltd. Description and Business Overview
Table 107. Piramal Enterprises Ltd. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Piramal Enterprises Ltd. Female Contraception Product
Table 109. Piramal Enterprises Ltd. Recent Developments/Updates
Table 110. Afaxys Pharma LLC Company Information
Table 111. Afaxys Pharma LLC Description and Business Overview
Table 112. Afaxys Pharma LLC Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Afaxys Pharma LLC Female Contraception Product
Table 114. Afaxys Pharma LLC Recent Developments/Updates
Table 115. Agile Therapeutics Inc. Company Information
Table 116. Agile Therapeutics Inc. Description and Business Overview
Table 117. Agile Therapeutics Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Agile Therapeutics Inc. Female Contraception Product
Table 119. Agile Therapeutics Inc. Recent Developments/Updates
Table 120. Bayer AG Company Information
Table 121. Bayer AG Description and Business Overview
Table 122. Bayer AG Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Bayer AG Female Contraception Product
Table 124. Bayer AG Recent Developments/Updates
Table 125. CooperSurgical Inc. Company Information
Table 126. CooperSurgical Inc. Description and Business Overview
Table 127. CooperSurgical Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. CooperSurgical Inc. Female Contraception Product
Table 129. CooperSurgical Inc. Recent Developments/Updates
Table 130. Cupid Ltd. Company Information
Table 131. Cupid Ltd. Description and Business Overview
Table 132. Cupid Ltd. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Cupid Ltd. Female Contraception Product
Table 134. Cupid Ltd. Recent Developments/Updates
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Johnson & Johnson Female Contraception Product
Table 139. Johnson & Johnson Recent Developments/Updates
Table 140. Mayer Laboratories Inc. Company Information
Table 141. Mayer Laboratories Inc. Description and Business Overview
Table 142. Mayer Laboratories Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Mayer Laboratories Inc. Female Contraception Product
Table 144. Mayer Laboratories Inc. Recent Developments/Updates
Table 145. Teva Pharmaceutical Industries Ltd Company Information
Table 146. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 147. Teva Pharmaceutical Industries Ltd Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Teva Pharmaceutical Industries Ltd Female Contraception Product
Table 149. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 150. Actavis, Inc. Company Information
Table 151. Actavis, Inc. Description and Business Overview
Table 152. Actavis, Inc. Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Actavis, Inc. Female Contraception Product
Table 154. Actavis, Inc. Recent Developments/Updates
Table 155. Gedeon Richter Company Information
Table 156. Gedeon Richter Description and Business Overview
Table 157. Gedeon Richter Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Gedeon Richter Female Contraception Product
Table 159. Gedeon Richter Recent Developments/Updates
Table 160. Novo Nordisk A/S Company Information
Table 161. Novo Nordisk A/S Description and Business Overview
Table 162. Novo Nordisk A/S Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Novo Nordisk A/S Female Contraception Product
Table 164. Novo Nordisk A/S Recent Developments/Updates
Table 165. ZiZhu Company Information
Table 166. ZiZhu Description and Business Overview
Table 167. ZiZhu Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. ZiZhu Female Contraception Product
Table 169. ZiZhu Recent Developments/Updates
Table 170. Baijingyu Company Information
Table 171. Baijingyu Description and Business Overview
Table 172. Baijingyu Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Baijingyu Female Contraception Product
Table 174. Baijingyu Recent Developments/Updates
Table 175. Huazhong Company Information
Table 176. Huazhong Description and Business Overview
Table 177. Huazhong Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Huazhong Female Contraception Product
Table 179. Huazhong Recent Developments/Updates
Table 180. Sine Company Information
Table 181. Sine Description and Business Overview
Table 182. Sine Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Sine Female Contraception Product
Table 184. Sine Recent Developments/Updates
Table 185. AbbVie Company Information
Table 186. AbbVie Description and Business Overview
Table 187. AbbVie Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. AbbVie Female Contraception Product
Table 189. AbbVie Recent Developments/Updates
Table 190. Church & Dwight Company Information
Table 191. Church & Dwight Description and Business Overview
Table 192. Church & Dwight Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 193. Church & Dwight Female Contraception Product
Table 194. Church & Dwight Recent Developments/Updates
Table 195. Reckitt Company Information
Table 196. Reckitt Description and Business Overview
Table 197. Reckitt Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 198. Reckitt Female Contraception Product
Table 199. Reckitt Recent Developments/Updates
Table 200. TherapeuticsMD Company Information
Table 201. TherapeuticsMD Description and Business Overview
Table 202. TherapeuticsMD Female Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 203. TherapeuticsMD Female Contraception Product
Table 204. TherapeuticsMD Recent Developments/Updates
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. Female Contraception Distributors List
Table 208. Female Contraception Customers List
Table 209. Female Contraception Market Trends
Table 210. Female Contraception Market Drivers
Table 211. Female Contraception Market Challenges
Table 212. Female Contraception Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
Table 216. Authors List of This Report
List of Figures
Figure 1. Product Picture of Female Contraception
Figure 2. Global Female Contraception Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Female Contraception Market Share by Type: 2025 & 2032
Figure 4. Birth Control Pills Product Picture
Figure 5. Contraceptive Injection Product Picture
Figure 6. Contraceptive Patch Product Picture
Figure 7. IUDs Product Picture
Figure 8. Female Condom Product Picture
Figure 9. Others Product Picture
Figure 10. Global Female Contraception Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Female Contraception Market Share by Application: 2025 & 2032
Figure 12. 18-25 Years Old
Figure 13. 26-35 Years Old
Figure 14. 36-45 Years Old
Figure 15. ＞45 Years Old
Figure 16. Others
Figure 17. Global Female Contraception Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Female Contraception Market Size (US$ Million), 2021–2032
Figure 19. Global Female Contraception Sales (K Units), 2021–2032
Figure 20. Global Female Contraception Average Price (US$/Unit), 2021–2032
Figure 21. Female Contraception Report Years Considered
Figure 22. Female Contraception Sales Share by Manufacturers in 2025
Figure 23. Global Female Contraception Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Female Contraception Players: Market Share by Revenue in Female Contraception in 2025
Figure 25. Female Contraception Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Female Contraception Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Female Contraception Sales Market Share by Country (2021–2032)
Figure 28. North America Female Contraception Revenue Market Share by Country (2021–2032)
Figure 29. United States Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Female Contraception Sales Market Share by Country (2021–2032)
Figure 32. Europe Female Contraception Revenue Market Share by Country (2021–2032)
Figure 33. Germany Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Female Contraception Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Female Contraception Revenue Market Share by Region (2021–2032)
Figure 40. China Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Female Contraception Sales Market Share by Country (2021–2032)
Figure 48. Latin America Female Contraception Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Female Contraception Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Female Contraception Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE Female Contraception Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Female Contraception by Type (2021–2032)
Figure 59. Global Revenue Market Share of Female Contraception by Type (2021–2032)
Figure 60. Global Female Contraception Price (US$/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of Female Contraception by Application (2021–2032)
Figure 62. Global Revenue Market Share of Female Contraception by Application (2021–2032)
Figure 63. Global Female Contraception Price (US$/Unit) by Application (2021–2032)
Figure 64. Female Contraception Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
